NCT03380351View on ClinicalTrials.gov

Specifying Interventions From the Sickle Cell Disease Implementation Consortium (SCDIC)

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

August 26, 2019

Primary Completion Date

March 1, 2024

Study Completion Date

March 30, 2024

Conditions
Anemia, Sickle Cell
Interventions
BEHAVIORAL

SCDIC interventions

The research team will characterize the intervention components and their implementation strategies.

Trial Locations (1)

63110

Washington University in St. Louis, St Louis

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Washington University School of Medicine

OTHER

NCT03380351 - Specifying Interventions From the Sickle Cell Disease Implementation Consortium (SCDIC) | Biotech Hunter | Biotech Hunter